Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The efficacy of topical agents used in wounds for managing chronic biofilm infections: A systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Management of MDR-TB in HIV co-infected patients in eastern europe: results from the TB:HIV study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Changes in Lyme neuroborreliosis incidence in Denmark, 1996 to 2015

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of neurological disorders in patients with European Lyme neuroborreliosis. A nationwide population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVES: Data describing long-term mortality in patients with Staphylococcus aureus bacteremia (SAB) is scarce. This study investigated risk factors, causes of death and temporal trends in long-term mortality associated with SAB.

METHODS: Nationwide population-based matched cohort study. Mortality rates and ratios for 25,855 cases and 258,547 controls were analyzed by Poisson regression. Hazard ratio of death was computed by Cox proportional hazards regression analysis.

RESULTS: The majority of deaths occurred within the first year of SAB (44.6%) and a further 15% occurred within the following 2-5 years. The mortality rate was 14-fold higher in the first year after SAB and 4.5-fold higher overall for cases compared to controls. Increasing age, comorbidity and hospital contact within 90 days of SAB was associated with an increased risk of death. The overall relative risk of death decreased gradually by 38% from 1992-1995 to 2012-2014. Compared to controls, SAB patients were more likely to die from congenital malformation, musculoskeletal/skin disease, digestive system disease, genitourinary disease, infectious disease, endocrine disease, injury and cancer and less likely to die from respiratory disease, nervous system disease, unknown causes, psychiatric disorders, cardiovascular disease and senility. Over time, rates of death decreased or were stable for all disease categories except for musculoskeletal and skin disease where a trend towards an increase was seen.

CONCLUSION: Long-term mortality after SAB was high but decreased over time. SAB cases were more likely to die of eight specific causes of death and less likely to die of five other causes of death compared to controls. Causes of death decreased for most disease categories. Risk factors associated with long-term mortality were similar to those found for short-term mortality. To improve long-term survival after SAB, patients should be screened for comorbidity associated with SAB.

Original languageEnglish
JournalJournal of Infection
Volume73
Issue number4
Pages (from-to)346-357
ISSN0163-4453
DOIs
Publication statusPublished - Oct 2016

ID: 48335431